Increased incidence of new-onset type-2 diabetes after cancer
It’s well-known that metabolic dysfunction, as seen in diabetes, is associated with a higher risk of cancer. But does the same applies the other way around? A newly published Danish cohort suggests so. Get elaboration in this MEDtalk with Associate Professor Lykke Sylow on how cancer induces metabolic dysfunction and new-onset type-2 diabetes.
Få tillgång
Om du är läkare, sjuksköterska eller annan vårdpersonal kan du komma åt hela artikeln genom att skapa en profil på BestPractice Nordic.
- Få tillgång
- Om du redan har en profil: Logga in